Evidence map›Paper›PMID 40366184›Full record

ArticleApplied and environmental microbiology2025

Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm).

Davide Amodeo, Serena Marchi, Lia Fiaschi, Luisa Raucci, Camilla Biba, Valentina Salvestroni, Claudia Maria Trombetta, Ilaria Manini, Maurizio Zazzi, Emanuele Montomoli and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied and environmental microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Davide AmodeoDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.ORCID 0000-0003-2022-9964
Serena MarchiDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Lia FiaschiDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Luisa RaucciDepartment of Biotechnology, chemistry and pharmacy, University of Siena, Siena, Italy.
Camilla BibaDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Valentina SalvestroniDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Claudia Maria TrombettaDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Ilaria ManiniDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Maurizio ZazziDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Emanuele MontomoliDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Ilaria VicentiDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Gabriele CeveniniDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Gabriele MessinaDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study evaluated the effects of violet-blue light (VBL) on cell viability and replication, carbonylation of three structural proteins (S, E, and N) and one non-structural protein (NSP13), and direct damage to the RNA of SARS-CoV-2. The virus was exposed to increasing doses of VBL along with influenza A and B viruses to compare their susceptibility. At the highest dose (21.6 J/cm

Indexed as

LightSARS-CoV-2Virus InactivationAnimalsBlue LightCell SurvivalChlorocebus aethiopsCOVID-19HumansInfluenza A virusInfluenza B virusMicrobial ViabilityRNA, ViralVero CellsVirus ReplicationRNA, Virallipid peroxidationprotein carbonylationreactive oxygen speciesSARS-CoV-2 envelopeviolet-blue light

Identifiers

PMID40366184
PMCPMC12175510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.